Status:
UNKNOWN
Effect of the Dietary Supplement Taxifolin Aqua on the Recovery Period After COVID-19 Pneumonia
Lead Sponsor:
Pirogov Russian National Research Medical University
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Objective of the study is to evaluate the effect of Taxifolin Aqua therapy on the indicators of respiratory function, the state of the arterial wall, the contractile function of the myocardium, as wel...
Detailed Description
The study will include 100 patients who had covid pneumonia 3 months ago. If the inclusion / exclusion criteria are met, the patient is asked to sign an informed consent to participate in the study. C...
Eligibility Criteria
Inclusion
- Patients of both sexes who had covid pneumonia 3 months ago and signed an informed consent and aged 18+.
Exclusion
- Standard contraindications to Taxifolin Aqua use.
Key Trial Info
Start Date :
May 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04871802
Start Date
May 10 2021
End Date
October 1 2021
Last Update
May 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Russian Clinical Research Center for Gerontology
Moscow, Russia, 129226